Pharmacist-led service for improving cardiometabolic risk and metabolic syndrome for people with severe mental illness

Individuals with severe mental illness (SMI), such as schizophrenia and bipolar affective disorder, have a higher risk of physical illness than those without SMI[1]. These physical illnesses exist within the general population, but the incidence and impact on morbidity and mortality in those with SMI is significantly ...
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research